Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Logusfer is a dietary supplement developed by Logus Pharma, specifically formulated to address iron deficiency and support healthy hematopoiesis. It contains microencapsulated iron pyrophosphate, a form of iron designed to enhance bioavailability and minimize common gastrointestinal side effects such as nausea and constipation. The formulation is further enriched with Vitamin C (ascorbic acid) to facilitate intestinal iron absorption, as well as Folic Acid and Vitamin B12 (cyanocobalamin) to support red blood cell production and overall metabolic function. Logusfer is primarily marketed for individuals with increased iron requirements, such as pregnant women, or those suffering from iron-deficiency anemia and chronic fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Logusfer.